{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:10:34Z","timestamp":1791774634877,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43504-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:14:21Z","timestamp":1773767661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glucocorticoid sparing in rheumatoid arthritis patients treated with Janus kinase inhibitors: insights from the Japanese patient registry"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-0303","authenticated-orcid":false,"given":"Hirofumi","family":"Shoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"43504_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"AD Matteo","year":"2023","unstructured":"Matteo, A. D., Bathon, J. M. & Emery, P. Rheumatoid arthritis. Lancet 402, 2019\u20132033 (2023).","journal-title":"Lancet"},{"key":"43504_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/annrheumdis-2012-201491","volume":"71","author":"D Aletaha","year":"2012","unstructured":"Aletaha, D., Martinez-Avila, J., Kvien, T. K. & Smolen, J. S. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index. Ann. Rheum. Dis. 71, 1190\u20131196 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. 79, 685\u2013699 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR4","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Rheumatoid arthritis. NatRev Dis. Primer. 4, 18001 (2018).","journal-title":"NatRev Dis. Primer"},{"key":"43504_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/ard-2023-224270","volume":"83","author":"L van Ouwerkerk","year":"2024","unstructured":"van Ouwerkerk, L. et al. Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Ann. Rheum. Dis. 83, 65\u201371 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/annrheumdis-2021-221957","volume":"81","author":"M Boers","year":"2022","unstructured":"Boers, M. et al. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Ann. Rheum. Dis. 81, 925\u2013936 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR7","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1093\/rheumatology\/keaa785","volume":"60","author":"T Santiago","year":"2021","unstructured":"Santiago, T. et al. Patients\u2019 and rheumatologists\u2019 perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study. Rheumatology 60, 3334\u20133342 (2021).","journal-title":"Rheumatology"},{"key":"43504_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP van Staa","year":"2020","unstructured":"van Staa, T. P., Leufkens, H. G. H., Abenhaim, L., Zhang, B. & Cooper, C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39, 1383\u20131389 (2020).","journal-title":"Rheumatology"},{"key":"43504_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/art.42928","volume":"76","author":"BW Coburn","year":"2024","unstructured":"Coburn, B. W. et al. Association of cardiovascular outcomes with low-dose glucocorticoid prescription in patients with rheumatoid arthritis. Arthritis Rheumatol. 76, 1585\u20131593 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"43504_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/rheumatology\/keae544","volume":"64","author":"ZLM Hofman","year":"2025","unstructured":"Hofman, Z. L. M. et al. Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn? Rheumatology 64, 65\u201373 (2025).","journal-title":"Rheumatology"},{"key":"43504_CR11","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/rheumatology\/keae265","volume":"63","author":"R Watanabe","year":"2024","unstructured":"Watanabe, R. et al. Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Rheumatology 63, 2418\u20132426 (2024).","journal-title":"Rheumatology"},{"key":"43504_CR12","doi-asserted-by":"publisher","first-page":"e002792","DOI":"10.1136\/rmdopen-2022-002792","volume":"9","author":"G Adami","year":"2023","unstructured":"Adami, G. et al. Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs). RMD Open. 9, e002792 (2023).","journal-title":"RMD Open."},{"key":"43504_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2008.092866","volume":"68","author":"N Nishimoto","year":"2009","unstructured":"Nishimoto, N. et al. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann. Rheum. Dis. 68, 1580\u20131584 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR14","doi-asserted-by":"publisher","first-page":"keae455","DOI":"10.1093\/rheumatology\/keae455","volume":"64","author":"G Adami","year":"2025","unstructured":"Adami, G. et al. Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis. Rheumatology 64, keae455 (2025).","journal-title":"Rheumatology"},{"key":"43504_CR15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"T Matsui","year":"2007","unstructured":"Matsui, T. et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann. Rheum. Dis. 66, 1221\u20131226 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/mr\/roae006","volume":"34","author":"T Matsui","year":"2024","unstructured":"Matsui, T. et al. Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study. Mod. Rheumatol. 34, 881\u2013891 (2024).","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"43504_CR17","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/rheumatology\/keaf067","volume":"64","author":"H Shoda","year":"2025","unstructured":"Shoda, H., Matsui, T., Tohma, S. & Sawada, T. Evaluation of patient-based disease activity score (PDAS) in the Japanese rheumatoid arthritis patient registry (NinJa registry). Rheumatology 64 (6), 3415\u20133425 (2025).","journal-title":"Rheumatology"},{"key":"43504_CR18","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Anna Rheum. Dis. 69, 1580\u20131588 (2010).","journal-title":"Anna Rheum. Dis."},{"key":"43504_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","volume":"140","author":"O Stenbrocker","year":"1949","unstructured":"Stenbrocker, O., Traeger, C. H. & Batterman, R. C. Therapeutic criteria in rheumatoid arthritis. J. Am. Med. Assoc. 140, 659\u2013662 (1949).","journal-title":"J. Am. Med. Assoc."},{"key":"43504_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.23342","volume":"59","author":"EH Choy","year":"2008","unstructured":"Choy, E. H., Khoshaba, B., Cooper, D., MacGregor, A. & Scott, D. L. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice. Arthritis Rheum. 59, 192\u2013199 (2008).","journal-title":"Arthritis Rheum."},{"key":"43504_CR21","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/rheumatology\/keaf067","volume":"64","author":"H Shoda","year":"2025","unstructured":"Shoda, H., Matsui, T., Shigeto, T. & Sawada, T. Evaluation of patient-based disease activity score (PDAS) in the Japanese rheumatoid arthritis patient registry (NinJa registry). Rheumatol. (Oxford). 64, 3415\u20133425 (2025).","journal-title":"Rheumatol. (Oxford)"},{"key":"43504_CR22","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/sim.3150","volume":"27","author":"PC Austin","year":"2008","unstructured":"Austin, P. C. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat. Med. 27, 2037\u20132049 (2008).","journal-title":"Stat. Med."},{"key":"43504_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.21037\/atm-20-3998","volume":"9","author":"QY Zhao","year":"2021","unstructured":"Zhao, Q. Y. et al. Propensity score matching with R: conventional methods and new features. Ann. Transl Med. 9, 812 (2021).","journal-title":"Ann. Transl Med."},{"key":"43504_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"43504_CR25","first-page":"1","volume":"59","author":"T Dustin","year":"2014","unstructured":"Dustin, T., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. Mediation: R package for causal mediation analysis. J. Stat. Soft. 59, 1\u201338 (2014).","journal-title":"J. Stat. Soft"},{"key":"43504_CR26","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1136\/annrheumdis-2016-210135","volume":"76","author":"C Roubille","year":"2017","unstructured":"Roubille, C. et al. Seven-Year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort. Ann. Rheum. Dis. 76, 1797\u20131802 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"43504_CR27","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/rheumatology\/kes079","volume":"51","author":"E McKeown","year":"2012","unstructured":"McKeown, E. et al. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the catch cohort. Rheumatology 51, 1662\u20131669 (2012).","journal-title":"Rheumatology"},{"key":"43504_CR28","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00296-015-3229-x","volume":"35","author":"K Albrecht","year":"2015","unstructured":"Albrecht, K., Callhoff, J., Schneider, M. & Zink, A. High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort. Rheumatol. Int. 35, 1377\u20131384 (2015).","journal-title":"Rheumatol. Int."},{"key":"43504_CR29","doi-asserted-by":"publisher","first-page":"e002700","DOI":"10.1136\/rmdopen-2022-002700","volume":"8","author":"L Tidblad","year":"2022","unstructured":"Tidblad, L., Westerlind, H., Delcoigne, B., Askling, J. & Saevarsdottir, S. Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD Open. 8, e002700 (2022).","journal-title":"RMD Open."},{"key":"43504_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/14397595.2021.1883251","volume":"31","author":"K Kumagai","year":"2021","unstructured":"Kumagai, K. et al. Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity. Mod. Rheumatol. 31, 1094\u20131099 (2021).","journal-title":"Mod. Rheumatol."},{"key":"43504_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/rheumatology\/keab503","volume":"61","author":"DF McWilliams","year":"2021","unstructured":"McWilliams, D. F. et al. The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis: a systematic literature review and meta-analysis. Rheumatology 61, 76\u201389 (2021).","journal-title":"Rheumatology"},{"key":"43504_CR32","doi-asserted-by":"publisher","first-page":"105671","DOI":"10.1016\/j.jbspin.2023.105671","volume":"91","author":"K Lauper","year":"2024","unstructured":"Lauper, K. et al. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies. Joint Bone Spine. 91, 105671 (2024).","journal-title":"Joint Bone Spine"},{"key":"43504_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.55563\/clinexprheumatol\/lfg83z","volume":"39","author":"FR Spinelli","year":"2021","unstructured":"Spinelli, F. R. et al. Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience. Clin. Exp. Rheumatol. 39, 525\u2013531 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"43504_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.55563\/clinexprheumatol\/pudtpo","volume":"39","author":"GM Guidelli","year":"2021","unstructured":"Guidelli, G. M. et al. Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study. Clin. Exp. Rheumatol. 39, 868\u2013873 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"43504_CR35","first-page":"keae455","volume":"21","author":"G Adami","year":"2024","unstructured":"Adami, G. et al. Glucocorticoid sparing effect of Janus kinase inhibitors compared to biological disease modifying anti-rheumatic drugs in rheumatoid arthritis, a single-center retrospective analysis. Rheumatology 21, keae455 (2024).","journal-title":"Rheumatology"},{"key":"43504_CR36","doi-asserted-by":"publisher","first-page":"152314","DOI":"10.1016\/j.semarthrit.2023.152314","volume":"64","author":"L Scheepers","year":"2024","unstructured":"Scheepers, L., Yang, Y., Chen, Y. L. & Graeme Jones, G. Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study. Semin Arthritis Rheum. 64, 152314 (2024).","journal-title":"Semin Arthritis Rheum."},{"key":"43504_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/acr.20405","volume":"63","author":"K Michaud","year":"2011","unstructured":"Michaud, K., Wallenstein, G. & Wolfe, F. Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients. Arthritis Care Res. (Hoboken). 63, 366\u2013372 (2011).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"43504_CR38","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/art.42640","volume":"75","author":"G Koduri","year":"2023","unstructured":"Koduri, G. & Solomon, J. J. Identification, monitoring, and management of rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 75, 2067\u20132077 (2023).","journal-title":"Arthritis Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43504-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43504-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43504-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:36:22Z","timestamp":1777502182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43504-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43504"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43504-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13796"}}